Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
Sales | 109,076 | 90,971 | 72,038 | 39,247 | 0 |
Cost of Goods | 7,298 | 8,150 | 6,620 | 5,131 | N/A |
Gross Profit | 101,778 | 82,821 | 65,418 | 34,116 | N/A |
Operating Expenses | 122,184 | 100,629 | 95,360 | 85,584 | 0 |
Operating Income | -20,108 | -17,658 | -29,322 | -51,337 | N/A |
Interest Expense | 282 | 272 | 268 | 265 | 0 |
Other Income | -3,255 | 4,138 | 108,453 | 973 | 0 |
Pre-tax Income | -23,645 | -13,792 | 78,863 | -50,629 | 0 |
Income Tax | 1,301 | -35 | -885 | -565 | N/A |
Net Income Continuous | -24,946 | -13,757 | 79,748 | -50,064 | N/A |
Net Income | $-24,946 | $-13,757 | $79,748 | $-50,064 | $N/A |
EPS Basic Total Ops | -0.65 | -0.48 | 2.52 | -1.68 | N/A |
EPS Basic Continuous Ops | -0.80 | -0.44 | 2.57 | -1.62 | N/A |
EPS Diluted Total Ops | -0.65 | -0.48 | 2.52 | -1.68 | N/A |
EPS Diluted Continuous Ops | -0.76 | -0.44 | 2.54 | -1.62 | N/A |
EPS Diluted Before Non-Recurring Items | -0.84 | -0.48 | -0.78 | N/A | N/A |
EBITDA(a) | $-17,964 | $-15,370 | $-26,931 | $-48,920 | $N/A |